Cancer, metastasis, and the epigenome
S Kiri, T Ryba - Molecular Cancer, 2024 - Springer
Cancer is the second leading cause of death worldwide and disease burden is expected to
increase globally throughout the next several decades, with the majority of cancer-related …
increase globally throughout the next several decades, with the majority of cancer-related …
[HTML][HTML] Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors …
R Van den Brande, EMJ Cornips, M Peeters… - Journal of bone …, 2022 - Elsevier
Introduction Spinal metastases (SM) are a frequent complication of cancer and may lead to
pathologic vertebral compression fractures (pVCF) and/or metastatic epidural spinal cord …
pathologic vertebral compression fractures (pVCF) and/or metastatic epidural spinal cord …
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis
S Kaczanowska, DW Beury, V Gopalan, AK Tycko… - Cell, 2021 - cell.com
Metastasis is the leading cause of cancer-related deaths, and greater knowledge of the
metastatic microenvironment is necessary to effectively target this process …
metastatic microenvironment is necessary to effectively target this process …
Siglec-15/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis
Immunotherapy is a promising approach for treating metastatic breast cancer (MBC), offering
new possibilities for therapy. While checkpoint inhibitors have shown great progress in the …
new possibilities for therapy. While checkpoint inhibitors have shown great progress in the …
Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study
Bone is one of the most common sites of metastasis from advanced solid tumors. Bone
metastasis is a leading cause of pain and increases the risk of skeletal-related events …
metastasis is a leading cause of pain and increases the risk of skeletal-related events …
Polymers and inorganic nanoparticles: A winning combination towards assembled nanostructures for cancer imaging and therapy
Inorganic nanoparticles show unique physical properties (eg, optical, electronic, magnetic
and catalytical properties), and highly tunable appearance characteristics (eg, size, shape …
and catalytical properties), and highly tunable appearance characteristics (eg, size, shape …
[HTML][HTML] Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody
Patients with solid tumours are at risk of impaired bone health from metastases and cancer
therapy-induced bone loss (CTIBL). We review medical management of bone health in …
therapy-induced bone loss (CTIBL). We review medical management of bone health in …
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
Although therapies of cancer are advancing, it remains challenging for therapeutics to reach
the sites of metastasis, which accounts for majority of cancer associated death. In this study …
the sites of metastasis, which accounts for majority of cancer associated death. In this study …
Radiomics for identification and prediction in metastatic prostate cancer: a review of studies
Metastatic Prostate Cancer (mPCa) is associated with a poor patient prognosis. mPCa
spreads throughout the body, often to bones, with spatial and temporal variations that make …
spreads throughout the body, often to bones, with spatial and temporal variations that make …
Bisphosphonate-based conjugates and derivatives as potential therapeutic agents in osteoporosis, bone cancer and metastatic bone cancer
Metastatic bone cancer occurs in every type of cancer but is prevalent in lung, breast, and
prostate cancers. These metastases can cause extensive morbidity, including a range of …
prostate cancers. These metastases can cause extensive morbidity, including a range of …